Cargando…
Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?
Alzheimer’s disease (AD) is a widespread neurodegenerative pathology responsible for about 70% of all cases of dementia. Adenosine is an endogenous nucleoside that affects neurodegeneration by activating four membrane G protein-coupled receptor subtypes, namely P1 receptors. One of them, the A(2A) s...
Autores principales: | Merighi, Stefania, Poloni, Tino Emanuele, Terrazzan, Anna, Moretti, Eva, Gessi, Stefania, Ferrari, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161210/ https://www.ncbi.nlm.nih.gov/pubmed/34065393 http://dx.doi.org/10.3390/cells10051267 |
Ejemplares similares
-
Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling
por: Ferrari, Davide, et al.
Publicado: (2022) -
A(2A) Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease
por: Gessi, Stefania, et al.
Publicado: (2021) -
An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
por: Merighi, Stefania, et al.
Publicado: (2021) -
Microglia and Alzheimer’s Disease
por: Merighi, Stefania, et al.
Publicado: (2022) -
Therapeutic Potential of Allicin and Aged Garlic Extract in Alzheimer’s Disease
por: Tedeschi, Paola, et al.
Publicado: (2022)